KROS company logo

Keros Therapeutics, Inc. Common Stock (KROS) Stock

NASDAQ · KROS
Trade KROS

Key stats

Market cap
$187.22M
Price / Earnings ratio
-3.0x
EPS (TTM)
-$2.33
Volume
Loading
52-week high
$22.55
52-week low
$8.98

Source: third-party data provider, as of November 13, 2026

Compare with KROS

Recent news

MarketBeat

Keros Therapeutics Eyes 2027 DMD Data as Rinvatercept Takes Center Stage

NeutralKROSOctober 22, 2026
Zacks Investment Research

KROS Begins Dosing in Phase II Study With Rinvatercept in DMD

NeutralKROSSeptember 29, 2026
Zacks Investment Research

Why Is Keros Therapeutics (KROS) Up 8% Since Last Earnings Report?

PositiveKROSSeptember 2, 2026
Zacks Investment Research

Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?

NeutralKROSAugust 24, 2026

News tone: automated (AI) classification of the article's content, not a price prediction.

Technical indicators

RSI 14
33.73
MACD 12/26/9
-0.48
EMA 9 of MACD
-0.28
MACD histogram
-0.20
SMA 50
$11.08
Price below SMA 50
EMA 50
$10.85
Price below EMA 50
SMA 200
$11.70
Price below SMA 200
EMA 200
$12.68
Price below EMA 200

Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.

Analyst ratings

No analyst data available

Financials

Performance

Revenue
Net income
Net margin %
2021
2022
2023
2024
2025
293M193M97M0

Debt & Balance Sheet

Total assets
Total liabilities
2021
2022
2023
2024
2025
739M488M244M0

Revenue to Profit

2025
$244.1M
Revenue
$0.0
Cost of revenue
$244.1M
Gross profit
$0.0
Operating expenses
$87.0M
Net income

Earnings

No data available

Source: third-party data provider

Stocks in the same sector

INCY
Incyte
NKTR
Nektar Therapeutics
REGN
Regeneron
VRTX
Vertex Pharmaceuticals
ABEO
Abeona Therapeutics Inc.
ACIU
AC IMMUNE SA
ACAD
ACADIA Pharma
ADPT
Adaptive Biotech

FAQ

Buying Keros Therapeutics, Inc. Common Stock (KROS) stock is now easy and instant through the Gotrade app.
  1. Download the Gotrade app from the App Store or Google Play.
  2. Create an account and verify your identity.
  3. Make a deposit.
  4. Search for the code "KROS", then tap "Trade".
  5. Tap the "Buy" button.
  6. Enter the amount you want to buy. You have two options:
    1. Buy KROS by number of shares.
    2. Buy fractional shares in dollars, starting from $1.
  7. Swipe up to confirm your order, and you're done!
On Gotrade, you don't have to buy a full share. With fractional shares, you can start investing in Keros Therapeutics, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.
At the moment, Keros Therapeutics, Inc. Common Stock (KROS) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track KROS's performance via the price chart in the Gotrade app.
Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).
You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too.
The market is closed on US public holidays. The Gotrade app shows whether the market is open.
There's no single perfect answer, but common approaches include:
  • Compare valuation (e.g., P/E, P/S) against historical averages or competitors.
  • Review revenue and earnings growth.
  • Check margins and cash flow.
  • Evaluate business outlook and the company's position within its industry.
You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.
Mockup Two Phones

Trade Faster. Easier. Smarter.

#ReadyGoTrade

Gotrade Green Logo Top Left

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply